A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology.
作者: Matteo M TruccoOla AwadBreelyn A WilkySeth D GoldsteinRuili HuangRobert L WalkerPreeti ShahVaralakshmi KaturiNaheed GulYuelin J ZhuEdward F McCarthyIdo Paz-PrielPaul S MeltzerChristopher P AustinMenghang XiaDavid M Loeb
刊名: PLoS ONE, 2017, Vol.8 (11)
来源数据库: Directory of Open Access Journals
DOI: 10.1371/journal.pone.0079950
原始语种摘要: Chordoma is a rare primary bone malignancy that arises in the skull base, spine and sacrum and originates from remnants of the notochord. These tumors are typically resistant to conventional chemotherapy, and to date there are no FDA-approved agents to treat chordoma. The lack of in vivo models of chordoma has impeded the development of new therapies for this tumor. Primary tumor from a sacral chordoma was xenografted into NOD/SCID/IL-2R γ-null mice. The xenograft is serially transplantable and was characterized by both gene expression analysis and whole genome SNP genotyping. The NIH Chemical Genomics Center performed high-throughput screening of 2,816 compounds using two established chordoma cell lines, U-CH1 and U-CH2B. The screen yielded several compounds that showed activity and two,...
全文获取路径: DOAJ  (合作)
分享到:
来源刊物:
影响因子:3.73 (2012)

×
关键词翻译
关键词翻译
  • chordoma 脊琐
  • xenograft 异种移植片
  • importance 重要性
  • transplantable 可移植性
  • novel 长篇小说
  • malignancy 恶性
  • sacrum 荐骨
  • serially 连续
  • screening 筛分
  • preclinical 临证前期的